Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia

British Journal of Pharmacology

Volumn 144, Issue 6, 2005, Pages 772-780

  Crocker, Ian P ^a   Kenny, Louise C ^a   Thornton, Wayne A ^a   Szabo, Csaba ^b,c   Baker, Philip N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INOTEK CORPORATION   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Endothelium; Poly(ADP ribose) polymerase; Pre eclampsia; Pregnancy

Indexed keywords

ADENOSINE TRIPHOSPHATE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ADULT; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL DAMAGE; CLINICAL ARTICLE; DIABETES MELLITUS; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; REPERFUSION; SHOCK; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATE; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ARTERIES; CASE-CONTROL STUDIES; CATTLE; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MIDDLE AGED; MYOMETRIUM; OXIDATIVE STRESS; PHENANTHRENES; PLASMA; POLY(ADP-RIBOSE) POLYMERASES; PRE-ECLAMPSIA; PREGNANCY; REACTIVE OXYGEN SPECIES; TIME FACTORS; TYROSINE;

EID: 17144406056     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706055     Document Type: Article

References (49)

1. ANIM-NYAME, N., GAMBLE, J., SOORANNA, S.R., JOHNSON, M.R. & STEER, P.J. (2003). Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia. Cardiovasc. Res., 58, 162-169.
2. ASHWORTH, J.R., WARREN, A.Y., BAKER, P.N. & JOHNSON, I.R. (1997). Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br. J. Obstet. Gynaecol., 104, 1152-1158.
3. ASHWORTH, J.R., WARREN, A.Y., JOHNSON, I.R. & BAKER, P.N. (1998). Plasma from pre-eclamptic women and functional change in myometrial resistance arteries. Br. J. Obstet. Gynaecol., 105, 459-461.
4. BAKER, P.N., DAVIDGE, S.T. & ROBERTS, J.M. (1995). Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension, 26, 244-248.
5. BARDEN, A., BEILIN, L.J., RITCHIE, J., CROFT, K.D., WALTERS, B.N. & MICHAEL, C.A. (1996). Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin. Sci. (Lond.), 91, 711-718.
6. BECKMAN, J.S. & KOPPENOL, W.H. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol., 271, C1424-3.
7. BURKART, V., WANG, Z.Q., RADONS, J., HELLER, B., HERCEG, Z., STINGL, L., WAGNER, E.F. & KOLB, H. (1999). Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat. Med., 5, 314-319.
8. CARL, B. & MARCELLA, S. (1973). An improved cycling assay for nicotinamide adenine dinucleotide. Anal. Biochem., 53, 452-458.
9. COATA, G., PENNACCHI, L., BINI, V., LIOTTA, L. & DI RENZO, G.C. (2002). Soluble adhesion molecules: marker of pre-eclampsia and intrauterine growth restriction. J. Matern. Fetal Neonat. Med., 12, 28-34.
10. CONRAD, K.P. & BENYO, D.F. (1997). Placental cytokines and the pathogenesis of preeclampsia. Am. J. Reprod. Immunol., 37, 240-249.
11. DAVIDGE, S.T. (1998). Oxidative stress and altered endothelial cell function in preeclampsia. Semin. Reprod. Endocrinol., 16, 65-73.
12. DAVIDGE, S.T., BAKER, P.N. & ROBERTS, J.M. (1995). NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am. J. Physiol., 269, H1106-12.
13. ELIASSON, M.J., SAMPEI, K., MANDIR, A.S., HURN, P.D., TRAYSTMAN, R.J., BAO, J., PIEPER, A., WANG, Z.Q., DAWSON, T.M., SNYDER, S.H. & DAWSON, V.L. (1997). Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med., 3, 1089-1095.
14. FRIEDMAN, S.A., SCHIFF, E., EMEIS, J.J., DEKKER, G.A. & SIBAI, B.M. (1995). Biochemical corroboration of endothelial involvement in severe preeclampsia. Am. J. Obstet. Gynecol., 172, 202-203.
15. GARDOSI, J. (1998). The application of individualised fetal growth curves. J. Perinat. Med., 26, 333-338.
16. HAYMAN, R., WARREN, A., BROCKELSBY, J., JOHNSON, I. & BAKER, P. (2000). Plasma from women with pre-eclampsia induces an in vitro alteration in the endothelium-dependent behaviour of myometrial resistance arteries. Bjog, 107, 108-115.
17. HUBEL, C.A. (1999). Oxidative stress in the pathogenesis of pre-eclampsia. Proc. Soc. Exp. Biol. Med., 222, 222-235.
18. HUBEL, C.A., MCLAUGHLIN, M.K., EVANS, R.W., HAUTH, B.A., SIMS, C.J. & ROBERTS, J.M. (1996). Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 h post partum. Am. J. Obstet. Gynecol., 174, 975-982.
19. KENNY, L.C., BAKER, P.N., KENDALL, D.A., RANDALL, M.D. & DUNN, W.R. (2002). Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin. Sci. (Lond.), 103, 67-73.
20. KNOCK, G.A. & POSTON, L. (1996). Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am. J. Obstet. Gynecol., 175, 1668-1674.
21. LAIN, K.Y. & ROBERTS, J.M. (2002). Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA, 287, 3183-3186.
22. LEE, V.M., QUINN, P.A., JENNINGS, S.C. & NG, L.L. (2003). Neutrophil activation and production of reactive oxygen species in pre-eclampsia. J. Hypertens., 21, 395-402.
23. LI, J.H., SERDYUK, L., FERRARIS, D.V., XIAO, G., TAYS, K.L., KLETZLY, P.W., LI, W., LAUTAR, S., ZHANG, J. & KALISH, V.J. (2001). Synthesis of substituted 5[H]phenanthridin-6-ones as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors. Bioorg. Med. Chem. Lett., 11, 1687-1690.
24. LUNELL, N.O., NYLUND, L., LEWANDER, R., SARBY, B. & WAGER, J. (1984). Uteroplacental blood flow in pregnancy hypertension after the administration of a beta-adrenoceptor blocker, pindolol. Gynecol. Obstet. Invest., 18, 269-274.
25. MCCARTHY, A.L., WOOLFSON, R.G., RAJU, S.K. & POSTON, L. (1993). Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am. J. Obstet. Gynecol., 168, 1323-1330.
26. MIKHAIL, M.S., ANYAEGBUNAM, A., GARFINKEL, D., PALAN, P.R., BASU, J. & ROMNEY, S.L. (1994). Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with pre-eclampsia. Am. J. Obstet. Gynecol., 171, 150-157.
27. OLIVER, F.J., MENISSIER-DE MURCIA, J., NACCI, C., DECKER, P., ANDRIANTSITOHAINA, R., MULLER, S., DE LA RUBIA, G., STOCLET, J.C. & DE MURCIA, G. (1999). Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J., 18, 4446-4454.
28. PIEPER, A.A., BRAT, D.J., KRUG, D.K., WATKINS, C.C., GUPTA, A., BLACKSHAW, S., VERMA, A., WANG, Z.Q. & SNYDER, S.H. (1999a). Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A., 96, 3059-3064.
29. PIEPER, A.A., VERMA, A., ZHANG, J. & SNYDER, S.H. (1999b). Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci., 20, 171-181.
30. PIEPER, A.A., WALLES, T., WEI, G., CLEMENTS, E.E., VERMA, A., SNYDER, S.H. & ZWEIER, J.L. (2000). Myocardial postischemic injury is reduced by poly(ADP-ripose) polymerase-1 gene disruption. Mol. Med., 6, 271-282.
31. ROBERTS, J.M., EDEP, M.E., GOLDFIEN, A. & TAYLOR, R.N. (1992). Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am. J. Reprod. Immunol., 27, 101-108.
32. ROBERTS, J.M. & LAIN, K.Y. (2002). Recent insights into the pathogenesis of pre-eclampsia. Placenta, 23, 359-372.
33. ROBERTS, J.M. & REDMAN, C.W. (1993). Pre-eclampsia: more than pregnancy-induced hypertension. Lancet, 341, 1447-1451.
34. ROBERTS, J.M., TAYLOR, R.N. & GOLDFIEN, A. (1991). Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am. J. Hypertens., 4, 700-708.
35. ROBERTS, J.M., TAYLOR, R.N., MUSCI, T.J., RODGERS, G.M., HUBEL, C.A. & MCLAUGHLIN, M.K. (1989). Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol., 161, 1200-1204.
36. ROGGENSACK, A.M., ZHANG, Y. & DAVIDGE, S.T. (1999). Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension, 33, 83-89.
37. ROYAL COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS. Why mothers die, (1997-1999). Report on the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press, 2001.
38. SCALERA, F., SCHLEMBACH, D. & BEINDER, E. (2001). Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. Eur. J. Obstet. Gynecol. Reprod. Biol., 99, 172-178.
39. SORIANO, F.G., VIRAG, L. & SZABO, C. (2001). Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J. Mol. Med., 79, 437-448.
40. SOUTHAN, G.J. & SZABO, C. (2003). Poly(ADP-ribose) polymerase inhibitors. Curr. Med. Chem., 10, 321-340.
41. SZABO, C., CUZZOCREA, S., ZINGARELLI, B., O'CONNOR, M. & SALZMAN, A.L. (1997). Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J. Clin. Invest., 100, 723-735.
42. VEDERNIKOV, Y.P., BELFORT, M.A., SAADE, G.R. & GARFIELD, R.E. (2001). Inhibition of cyclooxygenase but not nitric oxide synthase influences effects on the human omental artery of the thromboxane A2 mimetic U46619 and 17beta-estradiol. Am. J. Obstet. Gynecol., 185, 182-189.
43. VIRAG, L. & SZABO, C. (2002). The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev., 54, 375-429.
44. WANG, Y. & WALSH, S.W. (1996). Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J. Soc. Gynecol. Invest., 3, 179-184.
45. WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI. (2001). Ethical principles for medical research involving human subjects. Bull. World Health Organ., 78, 373-374.
46. YOREK, M.A. (2003). The role of oxidative stress in diabetic vascular and neural disease. Free Radic. Res., 37, 471-480.
47. ZHANG, Y., GU, Y., LI, H., LUCAS, M.J. & WANG, Y. (2003). Increased endothelial monolayer permeability is induced by serum from women with preeclampsia but not by serum from women with normal pregnancy or that are not pregnant. Hypertens. Pregnancy, 22, 99-108.
48. ZHOU, Y., FISHER, S.J., JANATPOUR, M., GENBACEV, O., DEJANA, E., WHEELOCK, M. & DAMSKY, C.H. (1997). Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J. Clin. Invest., 99, 2139-2151.
49. ZINGARELLI, B., SALZMAN, A.L. & SZABO, C. (1998). Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ. Res., 83, 85-94.